XIFAXAN

This brand name is authorized in Australia, Brazil, Hong Kong, Malta, Netherlands, New Zealand, Poland, Singapore, United States

Active ingredients

The drug XIFAXAN contains one active pharmaceutical ingredient (API):

1 Rifaximin UNII L36O5T016N - RIFAXIMIN

Rifaximin is an antibacterial agent of the rifamycin class that inhibits bacterial RNA synthesis. Rifaximin has a broad antimicrobial spectrum against most of the Gram-positive and -negative, aerobic and anaerobic bacteria responsible for intestinal infections. Read about Rifaximin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
XIFAXAN Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07AA11	Rifaximin	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10001J
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 504120070069507, 504120070069607, 504120070069707
Country: HK	Department of Health Drug Office	Identifier(s): 61689
Country: MT	Medicines Authority	Identifier(s): AA565/61701
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 105430
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15765
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100041059, 100136529, 100203600, 100257606, 100264486, 100286832, 100375085, 100386692, 100398442, 100416542, 100416938, 100417323, 100417636, 100439402
Country: SG	Health Sciences Authority	Identifier(s): 14761P
Country: US	FDA, National Drug Code	Identifier(s): 55154-6777, 65649-301, 65649-303